Phase I trial of Total Marrow and Lymphoid Irradiation Transplantation Conditioning

Not Applicable

• Conditions: Hematologic malignancy

• Registration Number: JPRN-UMIN000037581
• Lead Sponsor: Tokyo Metropolitan Cancer and Infectious Diseases Center Komagome Hospital

Brief Summary

Not available

Detailed Description

Not available

Study Timeline

• Results First Posted: 1900-01-01
• Study Start: 2019-08-02
• Study Completion: 2022-07-31
• Last Update Posted: 17 October 2023

Recruitment & Eligibility

• Status: Complete: follow-up complete
• Sex: All
• Target Recruitment: 9

Inclusion Criteria

Not provided

Exclusion Criteria

1. with active extramedullary lesion 2. disease status is non-CR 3. with active another malignant disease 4. Restlessness 5. with pregnant or possible pregnant 6. with once or more HSCT history 7. Serious medical or psychological problems

Study & Design

• Study Type: Interventional
• Study Design: Not specified

Primary Outcome Measures

Name	Time	Method
Dose limited toxicities until 100 days after irradiation.